Literature DB >> 31152069

NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis.

Sushan Yang1, Shi Huang2, Lori B Daniels3, Joseph Yeboah4, Joao A C Lima5, Valentina Cannone6,7, John C Burnett8, Joshua A Beckman9, J Jeffrey Carr10, Thomas J Wang9, Deepak K Gupta9.   

Abstract

OBJECTIVE: Natriuretic peptides (NPs) are hormones with cardioprotective effects. NP levels vary by race; however, the pathophysiological consequences of lower NP levels are not well understood. We aimed to quantify the association between NPs and endothelial function as measured by flow-mediated dilation (FMD) and the contribution of NP levels to racial differences in endothelial function.
METHODS: In this cross-sectional study of 2938 Multi-Ethnic Study of Atherosclerosis participants (34% Caucasian, 20% African-American, 20% Asian-American and 26% Hispanic) without cardiovascular disease at baseline, multivariable linear regression models were used to examine the association between serum N-terminal pro-B-type NP (NT-proBNP) and natural log-transformed FMD. We also tested whether NT-proBNP mediated the relationship between race and FMD using the product of coefficients method.
RESULTS: Among African-American and Chinese-American individuals, lower NT-proBNP levels were associated with lower FMD, β=0.06 (95% CI: 0.03 to 0.09; p<0.001) and β=0.06 (95% CI: 0.02 to 0.09; p=0.002), respectively. Non-significant associations between NT-proBNP and FMD were found in Hispanic and Caucasian individuals. In multivariable models, endothelial function differed by race, with African-American individuals having the lowest FMD compared with Caucasians, p<0.001. Racial differences in FMD among African-Americans and Chinese-Americans were mediated in part by NT-proBNP levels (African-Americans, mediation effect: -0.03(95% CI: -0.05 to -0.01); Chinese-Americans, mediation effect: -0.03(95% CI: -0.05 to -0.01)).
CONCLUSIONS: Lower NP levels are associated with worse endothelial function among African-Americans and Chinese-Americans. A relative NP deficiency in some racial/ethnic groups may contribute to differences in vascular function. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cardiac risk factors and prevention; epidemiology

Year:  2019        PMID: 31152069      PMCID: PMC7179817          DOI: 10.1136/heartjnl-2019-314707

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

1.  B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years.

Authors:  Kai M Eggers; Bertil Lindahl; Per Venge; Lars Lind
Journal:  Am J Cardiol       Date:  2009-02-07       Impact factor: 2.778

Review 2.  New aspects of the interactions between the cardiovascular nitric oxide system and natriuretic peptides.

Authors:  María A Costa; Cristina T Arranz
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

3.  Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis).

Authors:  Deepak K Gupta; Lori B Daniels; Susan Cheng; Christopher R deFilippi; Michael H Criqui; Alan S Maisel; Joao A Lima; Hossein Bahrami; Philip Greenland; Mary Cushman; Russell Tracy; David Siscovick; Alain G Bertoni; Valentina Cannone; John C Burnett; John Jeffrey Carr; Thomas J Wang
Journal:  Am J Cardiol       Date:  2017-06-30       Impact factor: 2.778

4.  Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study.

Authors:  Martin Magnusson; Amra Jujic; Bo Hedblad; Gunnar Engström; Margaretha Persson; Joachim Struck; Nils G Morgenthaler; Peter Nilsson; Christopher Newton-Cheh; Thomas J Wang; Olle Melander
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

Review 5.  Natriuretic Peptides and Cardiometabolic Health.

Authors:  Deepak K Gupta; Thomas J Wang
Journal:  Circ J       Date:  2015-06-23       Impact factor: 2.993

6.  Racial and gender differences in endothelin-1.

Authors:  R R Evans; B G Phillips; G Singh; L Bauman J; A Gulati
Journal:  Am J Cardiol       Date:  1996-08-15       Impact factor: 2.778

7.  N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.

Authors:  Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
Journal:  Hypertension       Date:  2005-08-29       Impact factor: 10.190

Review 8.  Natriuretic peptides.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

9.  Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome.

Authors:  Narbeh Melikian; Philip Chowienczyk; Philip A MacCarthy; Ian L Williams; Stephen B Wheatcroft; Roy Sherwood; Christopher Gale; Ajay M Shah; Mark T Kearney
Journal:  Atherosclerosis       Date:  2007-07-24       Impact factor: 5.162

10.  Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.

Authors:  Aun Yeong Chong; Andrew D Blann; Jeetesh Patel; Bethan Freestone; Elizabeth Hughes; Gregory Y H Lip
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.